571 related articles for article (PubMed ID: 19388908)
21. [Oncolytic viral therapy for cancer therapy].
Shimoyama S; Nakao A
Nihon Rinsho; 2006 Mar; 64(3):589-96. PubMed ID: 16529053
[TBL] [Abstract][Full Text] [Related]
22. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.
Sinkovics JG; Horvath JC
Arch Immunol Ther Exp (Warsz); 2008 Dec; 56 Suppl 1():3s-59s. PubMed ID: 19104757
[TBL] [Abstract][Full Text] [Related]
23. Viruses - seeking and destroying the tumor program.
O'Shea CC
Oncogene; 2005 Nov; 24(52):7640-55. PubMed ID: 16299526
[TBL] [Abstract][Full Text] [Related]
24. Innate immunity, tumor microenvironment and oncolytic virus therapy: friends or foes?
Stanford MM; Breitbach CJ; Bell JC; McFadden G
Curr Opin Mol Ther; 2008 Feb; 10(1):32-7. PubMed ID: 18228179
[TBL] [Abstract][Full Text] [Related]
25. Future prospects for oncolytic therapy.
McCormick F
Oncogene; 2005 Nov; 24(52):7817-9. PubMed ID: 16299540
[TBL] [Abstract][Full Text] [Related]
26. Clinical development directions in oncolytic viral therapy.
Eager RM; Nemunaitis J
Cancer Gene Ther; 2011 May; 18(5):305-17. PubMed ID: 21436867
[TBL] [Abstract][Full Text] [Related]
27. Oncolytic virus therapy for prostate cancer.
Fukuhara H; Homma Y; Todo T
Int J Urol; 2010 Jan; 17(1):20-30. PubMed ID: 19832925
[TBL] [Abstract][Full Text] [Related]
28. Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions.
Liu TC; Kirn D
Cancer Res; 2007 Jan; 67(2):429-32. PubMed ID: 17234747
[TBL] [Abstract][Full Text] [Related]
29. Design of virotherapy for effective tumor treatment.
Garcia-Aragoncillo E; Hernandez-Alcoceba R
Curr Opin Mol Ther; 2010 Aug; 12(4):403-11. PubMed ID: 20677091
[TBL] [Abstract][Full Text] [Related]
30. Oncolytic adenoviruses expressing interleukin: a novel antitumour approach.
Pei DS; Zheng JN
Expert Opin Biol Ther; 2010 Jun; 10(6):917-26. PubMed ID: 20402550
[TBL] [Abstract][Full Text] [Related]
31. Oncolytic viral therapies - the clinical experience.
Aghi M; Martuza RL
Oncogene; 2005 Nov; 24(52):7802-16. PubMed ID: 16299539
[TBL] [Abstract][Full Text] [Related]
32. Exploiting synergies between radiation and oncolytic viruses.
Harrington KJ; Melcher A; Vassaux G; Pandha HS; Vile RG
Curr Opin Mol Ther; 2008 Aug; 10(4):362-70. PubMed ID: 18683101
[TBL] [Abstract][Full Text] [Related]
33. Diplomatic immunity: turning a foe into an ally.
Parato KA; Lichty BD; Bell JC
Curr Opin Mol Ther; 2009 Feb; 11(1):13-21. PubMed ID: 19169955
[TBL] [Abstract][Full Text] [Related]
34. Newcastle disease virus as an oncolytic agent.
Ravindra PV; Tiwari AK; Sharma B; Chauhan RS
Indian J Med Res; 2009 Nov; 130(5):507-13. PubMed ID: 20090097
[TBL] [Abstract][Full Text] [Related]
35. Gene therapy progress and prospects cancer: oncolytic viruses.
Liu TC; Kirn D
Gene Ther; 2008 Jun; 15(12):877-84. PubMed ID: 18418413
[TBL] [Abstract][Full Text] [Related]
36. The host response to cancer virotherapy.
Chiocca EA
Curr Opin Mol Ther; 2008 Feb; 10(1):38-45. PubMed ID: 18228180
[TBL] [Abstract][Full Text] [Related]
37. Oncolytic virotherapy with modified adenoviruses and novel therapeutic targets.
Halldén G; Portella G
Expert Opin Ther Targets; 2012 Oct; 16(10):945-58. PubMed ID: 22880939
[TBL] [Abstract][Full Text] [Related]
38. Oncolytic virotherapy of breast cancer.
Hartkopf AD; Fehm T; Wallwiener D; Lauer UM
Gynecol Oncol; 2011 Oct; 123(1):164-71. PubMed ID: 21764108
[TBL] [Abstract][Full Text] [Related]
39. RNA viruses as virotherapy agents.
Russell SJ
Cancer Gene Ther; 2002 Dec; 9(12):961-6. PubMed ID: 12522435
[TBL] [Abstract][Full Text] [Related]
40. The emerging role of viruses in the treatment of solid tumours.
Bourke MG; Salwa S; Harrington KJ; Kucharczyk MJ; Forde PF; de Kruijf M; Soden D; Tangney M; Collins JK; O'Sullivan GC
Cancer Treat Rev; 2011 Dec; 37(8):618-32. PubMed ID: 21232872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
